Faculty Associates

Noll L. Campbell

Contact Information
Email: campbenl@purdue.edu
Phone: 317-630-2214
Fax: 317-630-8776
Homepage: Homepage
Associate Professor of Pharmacy Practice

PubMed Listing
Google Scholar Listing

PDF icon View Vita

Education


PharmD Butler University Pharmacy 2002

Research Interests


adverse cognitive effects of medications in older adults, geriatric pharmacotherapy

Teaching Interests


geriatric pharmacotherapy, dementia

Grants


2019 - National Institute on Aging
2019 - National Institute on Aging

Selected Publications


Campbell NL, Holden RJ, Tang Q, Boustani MA, Teal E, Hillstrom J, Tu W, Clark DO, Callahan CM. Multi-component Behavioral Intervention To Reduce Exposure To Anticholinergics In Primary Care Older Adults. J Amer Geriatr Soc 2021; 2021 Mar 26. Doi: 10.1111/jgs.17121. Online Ahead Of Print..

Campbell NL, Holden R, Boustani MA. Preventing Alzheimer Disease By Deprescribing Anticholinergic Medications. JAMA Intern Med 2019 Jun; 179(8):1084-1093. Doi: 10.1001/jamainternmed.2019.0676. PMID: 31233087.

Campbell NL, Perkins AJ, Khan BA, Gao S, Farber MO, Boustani MA. Deprescribing In The Pharmacologic Management Of Delirium (de-PMD): A Randomized Trial In The Intensive Care Unit. J Am Geriatr Soc 2019 Apr;67(4):695-702. Doi:10.1111/jgs.15751.

Campbell NL, Lane KA, Gao S, Boustani M, Unverzagt F. Anticholinergics Increase Transition From Normal Cognition To Mild Cognitive Impairment In Community-dwelling Older Adults. Pharmacotherapy 2018 May;38(5):511-519. Doi: 10.1002/phar.2106. Epub 2018 Apr 25. PMID: 29600808. Https://doi.org/10.1002/phar.2106.

Campbell NL, Perkins AP, Gao S, Skaar TC, Li L, Hendrie HC, Fowler N, Callahan CM, Boustani MA. Adherence And Tolerability Of Alzheimers Disease Medications: A Pragmatic Randomized Trial. J Am Geriatri Soc 2017;65(7):1497-1504.


Report a Problem